NCT01377896View on ClinicalTrials.gov

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

CompletedOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
SchizophreniaBipolar DisordersMajor Depressive Disorders
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY